SCHEMBL2809201

SCHEMBL2809201

COC(=O)c1cccc(OC(C(C)C)C2CCNCC2)c1

nearest known ligand 0.46

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RAB9A P51151 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
HTT P42858 2/20 0.40
GAA P10253 1/20 0.40
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL754910 0.79 SMN1; SMN2 (0.52) TP53SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL2807802 0.78 EPHX2 (0.55) TP53SMN1; SMN2L3MBTL1
Hydrochloric Acid SCHEMBL14127514 0.77 EPHX2 (0.54) TP53SMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL6174966 0.77 SMN1; SMN2 (0.59) TP53SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL18851107 0.76 KMT2A (0.53) TP53SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL4238401 0.76 KMT2A (0.55) SMN1; SMN2RAB9AKMT2ANPC1HPGD
SCHEMBL670118 0.75 SLC6A2 (0.52) SMN1; SMN2RAB9ANPC1
Hydrochloric Acid SCHEMBL18824328 0.75 KMT2A (0.55) TP53SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL13962915 0.75 OPRD1 (0.41) TP53SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL18617749 0.74 HTR2C (0.60) TP53SMN1; SMN2NPC1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120321559-A1 HEXAHYDRO-PYRROLO-ISOQUINOLINE COMPOUNDS APODACA RICHARD (US) 2012-12-20 US disclosed
US-8273762-B2 Hexahydro-pyrrolo-isoquinoline compounds JANSSEN PHARMACEUTICA NV (BE) 2012-09-25 US disclosed
US-20100240648-A1 HEXAHYDRO-PYRROLO-ISOQUINOLINE COMPOUNDS JANSSEN PHARMACEUTICA NV (BE) 2010-09-23 US disclosed
US-7754882-B2 Hexahydro-pyrrolo-isoquinoline compounds JANSSEN PHARMACEUTICA NV (BE) 2010-07-13 US disclosed
EP-1893613-A1 HEXAHYDRO-PYRROLO-ISOQUINOLINE COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 2008-03-05 EP disclosed
WO-2006138604-A1 HEXAHYDRO-PYRROLO-ISOQUINOLINE COMPOUNDS FOR THE TREATMENT OF CNS DISORDERS JANSSEN PHARMACEUTICA N.V. (BE) 2006-12-28 WO disclosed
US-20060293316-A1 HEXAHYDRO-PYRROLO-ISOQUINOLINE COMPOUNDS JANSSEN PHARMACEUTICA N.V. (BE) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293316-A1 HEXAHYDRO-PYRROLO-ISOQUINOLINE COMPOUNDS HRH3, HRH1, HRH4 TP53 3555/4885SMN1; SMN2 3624/4885RAB9A 1286/4885
US-20100240648-A1 HEXAHYDRO-PYRROLO-ISOQUINOLINE COMPOUNDS HRH3, HRH1, HRH4 TP53 3555/4885SMN1; SMN2 3624/4885RAB9A 1286/4885
US-20120321559-A1 HEXAHYDRO-PYRROLO-ISOQUINOLINE COMPOUNDS HRH3, HRH1, HRH4 TP53 3555/4885SMN1; SMN2 3624/4885RAB9A 1286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.